Carlos E. Bueso‐Ramos

28.5k citations

386 papers · 14.7k indexed · 3 hit papers · h-index 59

Hematology top 0.05%
- Acute Myeloid Leukemia Research 198
- Chronic Myeloid Leukemia Treatments 70
Genetics top 0.05%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 88
- Chronic Lymphocytic Leukemia Research 77
Cancer Research top 0.5%
Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 85
Molecular Medicine top 0.5%
Rheumatology
- Eosinophilic Disorders and Syndromes 39
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 37
Oncology
- Viral-associated cancers and disorders 25

Co-authors: Hagop M. Kantarjian L. Jeffrey Medeiros Bharat B. Aggarwal Guillermo Garcia‐Manero Jörge E. Cortes George A. Călin Gabriel Lopez‐Berestein Jana Ferdin
Cited by: Hematology Genetics Cancer Research
Journals: The Journal of Experimental Medicine (1 paper)Journal of Clinical Oncology (12 papers)SHILAP Revista de lepidopterología (4 papers)
Partner nations: United States Germany China

In The Last Decade

Carlos E. Bueso‐Ramos

373 papers receiving 14.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Carlos E. Bueso‐Ramos

Since Specialization

Citations

This map shows the geographic impact of Carlos E. Bueso‐Ramos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos E. Bueso‐Ramos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos E. Bueso‐Ramos more than expected).

Fields of papers citing papers by Carlos E. Bueso‐Ramos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos E. Bueso‐Ramos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos E. Bueso‐Ramos. The network helps show where Carlos E. Bueso‐Ramos may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carlos E. Bueso‐Ramos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carlos E. Bueso‐Ramos Line = papers co-authored together Carlos E. Bueso‐Ramos links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multimodal spatial proteomic profiling in acute myeloid leukemia npj Precision Oncology ·Christopher Ly,Ivo Veletić,Christopher D. Pacheco,Enes Dasdemir,Fatima Zahra Jelloul,Sammy Ferri‐Borgogno,Akshay Basi,Javier A. Gomez,Jessica L. Root,Patrick K. Reville,Sonali Jindal,Sreyashi Basu,Padmanee Sharma,Andres Quesada,Carlos E. Bueso‐Ramos,Taghi Manshouri,Branko Cuglievan,Miriam B. Garcia,Jared K. Burks,Hussein A. Abbas	2025	0
2	Thymoma with aberrant expression of CD20: a potential diagnostic pitfall of B-cell lymphoma Blood ·Qing Wei,Carlos E. Bueso‐Ramos	2024	0
3	Myeloid/lymphoid neoplasms with FLT3 rearrangement Modern Pathology ·Guilin Tang,Wayne Tam,Nicholas J. Short,Prithviraj Bose,David Wu,Stephanie N. Hurwitz,Adam Bagg,Heesun J. Rogers,Eric D. Hsi,Andres Quesada,Wei Wang,Roberto N. Miranda,Carlos E. Bueso‐Ramos,L. Jeffrey Medeiros,Valentina Nardi,Robert P. Hasserjian,Daniel A. Arber,Attilio Orazi,Kathryn Foucar,Sa A. Wang	2021	25
4	Comparison of therapy‐related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study American Journal of Hematology ·Heesun J. Rogers,Xiaoqiong Wang,Yan Xie,Adam R. Davis,Beenu Thakral,Sa A. Wang,Gautam Borthakur,Miguel D. Cantu,Elizabeth Margolskee,John Kennedy Sydney Sir Philip,Madina Sukhanova,Adam Bagg,Carlos E. Bueso‐Ramos,Attilio Orazi,Daniel A. Arber,Eric D. Hsi,Robert P. Hasserjian	2020	22
5	MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphoma Human Pathology ·Kirill A. Lyapichev,Guilin Tang,Shaoying Li,M. James You,Tingsing J. Cheng,Roberto N. Miranda,Swaminathan P. Iyer,C. Cameron Yin,Sergej Konoplev,Carlos E. Bueso‐Ramos,Francisco Vega,L. Jeffrey Medeiros,Jie Xu	2020	10
6	Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1 Modern Pathology ·Andres Quesada,Guillermo Montalban‐Bravo,Rajyalakshmi Luthra,Keyur P. Patel,Koji Sasaki,Carlos E. Bueso‐Ramos,Joseph D. Khoury,Mark J. Routbort,Roland L. Bassett,Juliana E. Hidalgo‐Lόpez,Chong Zhao,Pei Lin,Sanam Loghavi,Chi Young Ok,Tapan M. Kadia,Courtney D. DiNardo,Hagop M. Kantarjian,Guillermo Garcia‐Manero,Rashmi Kanagal‐Shamanna	2020	13
7	DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high‐risk disease American Journal of Hematology ·Andres Quesada,Mark J. Routbort,Courtney D. DiNardo,Carlos E. Bueso‐Ramos,Rashmi Kanagal‐Shamanna,Joseph D. Khoury,Beenu Thakral,Zhuang Zuo,C. Cameron Yin,Sanam Loghavi,Chi Young Ok,Sa A. Wang,Zhenya Tang,Sarah A. Bannon,Christopher B. Benton,Guillermo Garcia‐Manero,Hagop M. Kantarjian,Rajyalakshmi Luthra,L. Jeffrey Medeiros,Keyur P. Patel	2019	71
8	Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor–resistant chronic lymphocytic leukemia with disease progression and Richter transformation Cancer ·Rashmi Kanagal‐Shamanna,Preetesh Jain,Keyur P. Patel,Mark J. Routbort,Carlos E. Bueso‐Ramos,Tahani Alhalouli,Joseph D. Khoury,Rajyalakshmi Luthra,Alessandra Ferrajoli,Michael J. Keating,Nitin Jain,Jan A. Burger,Zeev Estrov,William G. Wierda,Hagop M. Kantarjian,L. Jeffrey Medeiros	2018	77
9	Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation Leukemia Research ·Yasmin Abaza,Juliana E. Hidalgo‐Lόpez,Srđan Verstovšek,Elias Jabbour,Farhad Ravandi,Gautam Borthakur,Zeev Estrov,Yesid Alvarado,Jan A. Burger,Heather Schneider,Kelly A. Soltysiak,Yue Wei,Hagop M. Kantarjian,Carlos E. Bueso‐Ramos,Guillermo Garcia‐Manero	2018	8
10	Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000 Cancer ·Hagop M. Kantarjian,Courtney D. DiNardo,Graciela M. Nogueras‐González,Tapan M. Kadia,Elias Jabbour,Carlos E. Bueso‐Ramos,Susan O’Brien,Marina Konopleva,Nitin Jain,Naval Daver,Elizabeth J. Shpall,Richard E. Champlin,Aron Simkins,Guillermo Garcia‐Manero,Michael J. Keating,Xuelin Huang,Jörge E. Cortes,Sherry Pierce,Farhad Ravandi,Emil J. Freireich	2018	20
11	T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas American Journal of Clinical Pathology ·Tanu Goyal,Beenu Thakral,Sa A. Wang,Carlos E. Bueso‐Ramos,Min Shi,Dragan Jevremović,William G. Morice,Qian-Yun Zhang,Tracy I. George,Kathryn K Foucar,Siddharth Bhattacharyya,Adam Bagg,Heesun J. Rogers,Juraj Bodo,Lisa Durkin,Eric D. Hsi	2017	13
12	Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy Blood ·Wei Wang,Jörge E. Cortes,Guilin Tang,Joseph D. Khoury,Sa Wang,Carlos E. Bueso‐Ramos,Joseph A. DiGiuseppe,Zi Chen,Hagop M. Kantarjian,L. Jeffrey Medeiros,Shimin Hu	2016	111
13	Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens Clinical Cancer Research ·Katja Karjalainen,Diana E. Jaalouk,Carlos E. Bueso‐Ramos,Laura Bover,Yan Sun,Akihiko Kuniyasu,Wouter H. P. Driessen,Marina Cardó‐Vila,Cecilia Rietz,Amado J. Zurita,Susan O’Brien,Hagop M. Kantarjian,Jörge E. Cortes,George A. Călin,Erkki Koivunen,Wadih Arap,Renata Pasqualini	2015	11
14	Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients Human Pathology ·Mariko Yabe,L. Jeffrey Medeiros,Guilin Tang,Sa A. Wang,Keyur P. Patel,Mark J. Routbort,Govind Bhagat,Carlos E. Bueso‐Ramos,Jeffrey L. Jorgensen,Rajyalakshmi Luthra,Weina Chen,Tariq Muzzafar,Rashmi Kanagal‐Shamanna,Joseph D. Khoury,Yahya Daneshbod,Masoud Davanlou,Shaoying Li,Ken H. Young,Roberto N. Miranda	2015	11
15	Flow cytometry immunophenotypic findings in chronic myelomonocytic leukemia and its utility in monitoring treatment response European Journal Of Haematology ·Qi Shen,Juan Ouyang,Guilin Tang,Elias Jabbour,Guillermo Garcia‐Manero,Mark J. Routbort,Sergej Konoplev,Carlos E. Bueso‐Ramos,L. Jeffrey Medeiros,Jeffrey L. Jorgensen,Sa A. Wang	2014	24
16	Epstein‐Barr virus latent membrane protein 1 mRNA is expressed in a significant proportion of patients with chronic lymphocytic leukemia Cancer ·Jeffrey J. Tarrand,Michael J. Keating,Apostolia M. Tsimberidou,Susan O’Brien,Rocco P. LaSala,Xiang‐Yang Han,Carlos E. Bueso‐Ramos	2010	21
17	Precursor T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma and Acute Biphenotypic Leukemias American Journal of Clinical Pathology ·Xin Han,Carlos E. Bueso‐Ramos	2007	1
18	Precursor T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma and Acute Biphenotypic Leukemias American Journal of Clinical Pathology ·Xin Han,Carlos E. Bueso‐Ramos	2007	27
19	Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome Cancer ·Hagop M. Kantarjian,Susan O’Brien,Xuelin Huang,Guillermo Garcia‐Manero,Farhad Ravandi,Jörge E. Cortes,Jianqin Shan,Jan Davisson,Carlos E. Bueso‐Ramos,Jean‐Pierre J. Issa	2007	132
20	CD56 TdT blastic natural killer cell tumor of the skin Cancer ·Joseph D. Khoury,L. Jeffrey Medeiros,John T. Manning,Laura E. Sulak,Carlos E. Bueso‐Ramos,Dan Jones	2002	1

About Carlos E. Bueso‐Ramos

Carlos E. Bueso‐Ramos is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 386 papers that have together received 14.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (198 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (88 papers), Lymphoma Diagnosis and Treatment (85 papers), Chronic Lymphocytic Leukemia Research (77 papers), Chronic Myeloid Leukemia Treatments (70 papers), Eosinophilic Disorders and Syndromes (39 papers), Acute Lymphoblastic Leukemia research (37 papers) and Viral-associated cancers and disorders (25 papers). The work is most often cited by research in Hematology (6.0k citations), Genetics (4.3k citations) and Cancer Research (2.4k citations). Carlos E. Bueso‐Ramos has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Hagop M. Kantarjian, L. Jeffrey Medeiros, Bharat B. Aggarwal, Guillermo Garcia‐Manero, Jörge E. Cortes, George A. Călin, Gabriel Lopez‐Berestein, Jana Ferdin, María Angélica Cortez and Anil K. Sood. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact